Lorraine L. Lipscombe, MD, MSc
Lipscombe LL. In poorly controlled type 2 diabetes, oral semaglutide was noninferior to liraglutide for reducing HbA1c. Ann Intern Med. 2019;171:JC29. doi: 10.7326/ACPJ201909170-029
Download citation file:
Published: Ann Intern Med. 2019;171(6):JC29.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use